These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 26070384)
1. Combinatorial drug approaches to tackle Candida albicans biofilms. De Cremer K; Staes I; Delattin N; Cammue BP; Thevissen K; De Brucker K Expert Rev Anti Infect Ther; 2015 Aug; 13(8):973-84. PubMed ID: 26070384 [TBL] [Abstract][Full Text] [Related]
2. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans. Cui J; Ren B; Tong Y; Dai H; Zhang L Virulence; 2015; 6(4):362-71. PubMed ID: 26048362 [TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibility of Candida albicans in biofilms. Tobudic S; Kratzer C; Lassnigg A; Presterl E Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943 [TBL] [Abstract][Full Text] [Related]
4. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro. Ramage G; Jose A; Coco B; Rajendran R; Rautemaa R; Murray C; Lappin DF; Bagg J Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):456-60. PubMed ID: 21310633 [TBL] [Abstract][Full Text] [Related]
5. Candida albicans biofilms produce antifungal-tolerant persister cells. LaFleur MD; Kumamoto CA; Lewis K Antimicrob Agents Chemother; 2006 Nov; 50(11):3839-46. PubMed ID: 16923951 [TBL] [Abstract][Full Text] [Related]
6. Gentamicin synergises with azoles against drug-resistant Candida albicans. Lu M; Yu C; Cui X; Shi J; Yuan L; Sun S Int J Antimicrob Agents; 2018 Jan; 51(1):107-114. PubMed ID: 28943366 [TBL] [Abstract][Full Text] [Related]
7. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms. De Brucker K; De Cremer K; Cammue BP; Thevissen K Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100 [TBL] [Abstract][Full Text] [Related]
8. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species. Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416 [TBL] [Abstract][Full Text] [Related]
9. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans. Khan MS; Ahmad I J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355 [TBL] [Abstract][Full Text] [Related]
10. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms. Bink A; Kucharíková S; Neirinck B; Vleugels J; Van Dijck P; Cammue BP; Thevissen K J Infect Dis; 2012 Dec; 206(11):1790-7. PubMed ID: 22984120 [TBL] [Abstract][Full Text] [Related]
11. The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms. Vriens K; Cools TL; Harvey PJ; Craik DJ; Braem A; Vleugels J; De Coninck B; Cammue BP; Thevissen K Peptides; 2016 Jan; 75():71-9. PubMed ID: 26592804 [TBL] [Abstract][Full Text] [Related]
12. Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms. De Cremer K; Lanckacker E; Cools TL; Bax M; De Brucker K; Cos P; Cammue BP; Thevissen K Antimicrob Agents Chemother; 2015 Jan; 59(1):421-6. PubMed ID: 25367916 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms. Yu Q; Ding X; Xu N; Cheng X; Qian K; Zhang B; Xing L; Li M Int J Antimicrob Agents; 2013 Feb; 41(2):179-82. PubMed ID: 23265915 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Candida albicans biofilm. Tsui C; Kong EF; Jabra-Rizk MA Pathog Dis; 2016 Jun; 74(4):ftw018. PubMed ID: 26960943 [TBL] [Abstract][Full Text] [Related]
17. Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model. Ahmadi MS; Lee HH; Sanchez DA; Friedman AJ; Tar MT; Davies KP; Nosanchuk JD; Martinez LR Antimicrob Agents Chemother; 2016 Apr; 60(4):2185-94. PubMed ID: 26810653 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells. do Nascimento Dias J; de Souza Silva C; de Araújo AR; Souza JMT; de Holanda Veloso Júnior PH; Cabral WF; da Glória da Silva M; Eaton P; de Souza de Almeida Leite JR; Nicola AM; Albuquerque P; Silva-Pereira I Sci Rep; 2020 Jun; 10(1):10327. PubMed ID: 32587287 [TBL] [Abstract][Full Text] [Related]
19. In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp. Rosato A; Catalano A; Carocci A; Carrieri A; Carone A; Caggiano G; Franchini C; Corbo F; Montagna MT Bioorg Med Chem; 2016 Mar; 24(5):1002-5. PubMed ID: 26833243 [TBL] [Abstract][Full Text] [Related]
20. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans. Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]